Thurston Springer Miller Herd & Titak’s Boston Scientific BSX Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.6K	Buy	670 +57	+9%	+$3.1K	0.01%	595
2026 Q1	$38.5K	Sell	613 -6,391	-91%	-$511K	0.02%	600
2025 Q4	$668K	Buy	7,004 +5,288	+308%	+$518K	0.23%	107
2025 Q3	$168K	Sell	1,716 -23,573	-93%	-$2.44M	0.33%	95
2025 Q2	$2.72M	Buy	25,289 +4,394	+21%	+$445K	0.35%	76
2025 Q1	$2.11M	Buy	20,895 +15,310	+274%	+$1.54M	0.35%	77
2024 Q4	$499K	Buy	5,585 +1,799	+48%	+$158K	0.1%	179
2024 Q3	$317K	Buy	3,786 +927	+32%	+$73.1K	0.09%	203
2024 Q2	$220K	Buy	+2,859	New	+$209K	0.07%	290

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's BSX Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Boston Scientific (BSX) stake by 9.3% in Q2 2026, buying an estimated $3.1K and bringing the position to 670 shares worth $28.6K. The position accounts for 0.01% of the portfolio, ranked #595.

Thurston Springer Miller Herd & Titak first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.72M in Q2 2025. 425 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Thurston Springer Miller Herd & Titak held 670 shares of Boston Scientific worth $28.6K as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 57 Boston Scientific shares in Q2 2026, an estimated $3.1K.
Boston Scientific made up 0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #595 holding.
Thurston Springer Miller Herd & Titak first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's Boston Scientific position peaked at $2.72M in Q2 2025.
425 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.